- Fee assured
- Verified this account
This healthcare professional let us know that they are currently:
- Accepting new patients
- Available for:
- Phone consultations
- Video consultations
Last updated: 17 May 2020
- Inflammatory bowel disease
- Video and telephone consultations
Dr Naila Arebi graduated as a Doctor of Medicine from the University of Malta. She pursued her post-graduate training in Oxford and London leading to accreditation in Gastroenterology and General Medicine in 2004 followed by advanced endoscopy training at St Mark's Hospital. She was awarded a PhD from Imperial College University of London, supported by the Helicobacter Parkside Study Group. She received the Sybil McMichael Bursary in 2000 and Travel scholarships to visit Medical University of South Carolina Endoscopy Unit and Kishiwada Tokusyukai Hospital and Osaka University Hospital, Japan.
Following her appointment as a Consultant Gastroenterologist at St Mark's Hospital and an Honorary Senior Lecturer at Imperial College in 2005, she became a Fellow of the Royal College Physicians in 2010. Her clinical work involves most aspects of gastroenterology with key interest areas Inflammatory Bowel Disease, Irritable Bowel Syndrome and constipation. During her time as a consultant she set up the Bravo Catheterless pH monitoring service to support the oesophageal diagnostic service. She is currently the clinical lead for the IBD Service. Through the award of NIHR grant she led a strategic IBD service improvement project with the expansion of the IBD team and several new patient-centred services namely community, rapid access, biologics and new diagnosis clinics. She received awards for working in partnership with patients as the BMJ commended award and Brian Turley award. She held previous position as Chairman for St Mark’s medicine and leading a team of 28 Gastroenterologists across the Trust.
She is the director St Mark’s Prescribing biologics in IBD course. Her current research is focused on Inflammatory Bowel Disease, where she is the chief investigator on a number of research studies aimed at enhancing our understanding Inflammatory Bowel Disease, testing new treatments and improving the delivery care for patients through national and international collaborations. She is a reviewer for a number of international journals and grant funding bodies and an author on several peer-reviewed publications. On a national and international level, she sits on the British Society of Gastroenterology adolescents and young adults committee and European Crohn’s and Colitis Organisation as elected committee member.
Areas of interest
Gastroenterologist; Endoscopy;Colonoscopy; Inflammatory bowel disease (IBD); ulcerative colitis; crohn's disease; irritable bowel syndrome (IBS); diarrhoea; rectal bleeding; weight loss; colonic polyps; constipation; incontinence; indigestion; dyspepsia; heartburn; reflux disease; flexible sigmoidoscopy; gastroscopy; oesophageal physiology tests; ages 16 plus
Anaesthetists worked with
- Dr Peter Amoroso Not Fee Assured
- The London Clinic Hospital Page
- St Mark's Hospital Hospital Page
- Trustplus Clinical Services
- NorthwickPark Hospital NHS Trust
- Independant Doctors Federation
Current NHS consultant posts held
Consultant Gastroenterologist and Clinical Lead for the IBD Service at St Mark's Hospital, London
Honorary Senior Lecturer Imperial College, London
My research interests are focused on Inflammatory Bowel Disease. I have published over 60 research papers. At present, I am investigating the impact of early education on patient empowerment, the use of artifical intelligence to support clinical care and shared decision making for clinical treatments. I have expertise in epidemiology of inflammatory bowel disease, optimal therapy in disease management, management of dysplasia in ulcerative colitis and Crohn's disease, IBD in Adolescents and Young Adults, older onset IBD, perianal Crohn's disease.
2007 GSK Research Award
2010 3Cs Grant
2014 Vincent Mathews award: Epidemiology of UC in South Asians
2015 St Mark’s Foundation: Vedolizumab real world experience
2015 LNWH charitable Trust: Patient Know Best portal to manage patients with IBD
2016 NIHR CLAHRC quality improvement grant patient-centred IBD service
2016 St Mark’s Foundation award: Outcomes from the IBD database
2019 ECCO Pioneer grant
I am passionate about cycling and completed 280-mile charity cycle ride
Member of Arab International Women’s Forum (AIWF) supporting leadership for Arab women
1997 Parkside Helicobacter Study Group
1999 Sybil Mc Michael Bursary
2004 Key Med Award: USA
2004 Ferring Award: Japan
2009-2019 NHS Clinical Excellence Awards
2018 Brian Turley Award for Patient Involvement and Partnership
2018 BMJ award for Patient Partnership: The IBD Care Model Team
2018 R&D Excellence Awards
1. Caveats of retrospective data analyses from therapeutic drug monitoring clinical pathways. J Crohns Colitis. 2019 Nov 25. pii: jjz190.
2. Deficient Resident Memory T-Cell and Cd8 T-Cell Response to Commensals in Inflammatory Bowel Disease. J Crohns Colitis. 2019 Oct 26. pii: jjz175
3. Stratification of Inflammatory Bowel Disease outpatients by disease activity and risk of complications to guide out-of-hospital monitoring: a patient-centred quality improvement project. BMJ Open Qual. 2019 Aug 1;8(3):e000546.
4. Transitions of care across secondary-care settings in patients with inflammatory bowel disease in England: a retrospective analysis of hospital episode statistics. World J Gastroenterol. 2019 May 7;25(17):2122-2132
5. A prospective study of incidence and phenotype of inflammatory bowel disease in ethnic groups from the UK inception cohort epidemiological study (UNITE). World J Gastroenterol. 2019 Oct 28;25(40):6145-6157.
6. Disease course of inflammatory bowel disease unclassified in a European population-based inception cohort: An Epi-IBD study. J Gastroenterol Hepatol. 2019 Jun;34(6):996-1003.
7. The impact of therapeutic drug level monitoring on outcomes of patients with Crohn’s disease treated with Infliximab: results from a real world study. Frontline Gastroenterol. 2019 Oct;10(4):330-336.
Publications featured in
https://www.pressreader.com/uk/daily-mail/20180608/282578788738223 The doctors leading the way in gut conditions. Daily Mail 8 June 2018.
https://www.bmj.com/content/361/bmj.k1705: The BMJ Awards 2018
Courses offered to GPs
Diagnostic Pathway in Inflammatory Bowel Disease
Mistakes in inflammatory bowel disease and how to avoid them
Breath test for food intolerances
Caring for IBD with relapse and in remission
Calprotectin: Diagnostic Tool in IBS?
NAtional Endoscopy Database (NED) data showing above average colonoscopy caecal intubation rates as measure of endoscopy quality: rates 96.8% in 2019 and 95% in 2020. National average 92.8%.
- PhD University of London 2002
- MD University of Malta 1989
- MSc London School of Economics 2012
- Endoscopy St Mark's Hospital 2004
- Health Economics LSE 2010
Reference number 4574112
Details of entry to specialist register
- Naila Arebi Gastroenterology and General Medicine, 2004
Affiliations / memberships
Fellow of the Royal College of Physicians
British Society of Gastroenterology
European Crohn's and Colitis Organisation
- The London Clinic Consulting Rooms116 Harley...
- 13:00 - 17:00
- 020 3613 8075
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details
In the event of urgent query after the procedure please contact my secretary on 07491 685428, or london clinic endoscopy unit on 0207 616 7760. After hours please contact Matron at The London Clinic on 0207 935 4444 or Private Wing of St Mark's Hospital on 0208 869 3394/8.